United States · FDA National Drug Code directory

Guaifenesin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
58602-811_209f74eb-400d-40fe-943e-cecd8aec3a1d
Product NDC
58602-811
Form
TABLET, EXTENDED RELEASE
Composition / generic term
Guaifenesin
Labeler
Aurohealth LLC
Marketing category
ANDA
Marketing start / end (source format)
20191021
Source listing expiry
20261231

Source-listed ingredients

  • GUAIFENESIN — 1200 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 BLISTER PACK in 1 CARTON (58602-811-01) / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 58602-811-01
  • 2 BLISTER PACK in 1 CARTON (58602-811-02) / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 58602-811-02
  • 3 BLISTER PACK in 1 CARTON (58602-811-03) / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 58602-811-03
  • 1 BOTTLE in 1 CARTON (58602-811-05) / 14 TABLET, EXTENDED RELEASE in 1 BOTTLE · 58602-811-05
  • 1 BOTTLE in 1 CARTON (58602-811-12) / 40 TABLET, EXTENDED RELEASE in 1 BOTTLE · 58602-811-12
  • 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (58602-811-21) · 58602-811-21
  • 4 BLISTER PACK in 1 CARTON (58602-811-56) / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 58602-811-56
  • 1 BOTTLE in 1 CARTON (58602-811-57) / 28 TABLET, EXTENDED RELEASE in 1 BOTTLE · 58602-811-57
  • 1 BOTTLE in 1 CARTON (58602-811-60) / 42 TABLET, EXTENDED RELEASE in 1 BOTTLE · 58602-811-60
  • 1 BLISTER PACK in 1 CARTON (58602-811-64) / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 58602-811-64
  • 1 BOTTLE in 1 CARTON (58602-811-73) / 20 TABLET, EXTENDED RELEASE in 1 BOTTLE · 58602-811-73

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →